Literature DB >> 24531088

Penicilliosis marneffei complicated with interstitial pneumonia.

Haruhiko Furusawa1, Yasunari Miyazaki, Shiro Sonoda, Kimitake Tsuchiya, Takashi Yaguchi, Katsuhiko Kamei, Naohiko Inase.   

Abstract

A 71-year-old man with interstitial pneumonia was hospitalized due to a pulmonary infection. He had been living in Thailand and had returned to Japan three months earlier. Antibiotic therapy initially cleared the infection; however, the patient's condition relapsed. Pseudomonas aeruginosa and Penicillium sp. were both detected in sputum and bronchial lavage fluid cultures and Penicillium sp. was identified to be P. marneffei. The infiltration observed on chest radiographs improved following treatment with itraconazole and tazobactam/piperacillin, and no relapse occurred. We herein report the first case of a non-HIV patient with P. marneffei infection in Japan.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24531088     DOI: 10.2169/internalmedicine.53.1465

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient.

Authors:  Jiejun Shi; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2021-03-29

Review 2.  Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients.

Authors:  Jasper F W Chan; Susanna K P Lau; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

3.  Non-HIV talaromycosis: Radiological and clinical analysis.

Authors:  Xinchun Li; Wenqing Hu; Qi Wan; Qiang Lei; Chongpeng Sun; Zhongjun Hou; Nitesh Shrestha
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

Review 4.  Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

Authors:  Shanti Narayanasamy; John Dougherty; H Rogier van Doorn; Thuy Le
Journal:  Mycopathologia       Date:  2021-07-06       Impact factor: 2.574

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.